ARE THERE GENDER SPECIFIC DIFFERENCES IN PATIENT REPORTED OUTCOMES AT INITIATION OF GOLIMUMAB TREATMENT IN RHEUMATOID ARTHRITIS?

被引：0

作者：

Sholter, D. ^{[1
]}

Bensen, W. G. ^{[2
,3
]}

Choquette, D. ^{[4
]}

Fortin, I. ^{[5
]}

Arendse, R. ^{[6
]}

Kelsall, J. ^{[7
]}

Sheriff, M. ^{[8
]}

Faraawi, R. ^{[9
]}

Rodrigues, J. ^{[10
]}

Zummer, M. ^{[11
,12
]}

Dixit, S. ^{[9
]}

Starr, M. ^{[4
]}

Rampakakis, E. ^{[13
,14
]}

Sampalis, J. S. ^{[13
,14
]}

Nantel, F. ^{[15
]}

Shawi, M. ^{[15
]}

Otawa, S. ^{[15
]}

Lehman, A. J. ^{[15
]}

机构：

[1] Univ Alberta, Edmonton, AB, Canada

[2] St Joseph Hosp, Hamilton, ON, Canada

[3] McMaster Univ, Hamilton, ON, Canada

[4] Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada

[5] Ctr Rhumatol Est Quebec, Rimouski, PQ, Canada

[6] Univ Saskatchewan, Saskatoon, SK, Canada

[7] Mary Pack Arthrit Ctr, Vancouver, BC, Canada

[8] Nanaimo Reg Gen Hosp, Nanaimo, BC, Canada

[9] McMaster Univ, Hamilton, ON, Canada

[10] Clin Res & Arthrit Ctr, Windsor, ON, Canada

[11] Univ Montreal, Montreal, PQ, Canada

[12] Hop Maison Neuve Rosemont, Montreal, PQ, Canada

[13] McGill Univ, Montreal, PQ, Canada

[14] JSS Med Res, Montreal, PQ, Canada

[15] Janssen Inc Canada, Toronto, ON, Canada

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷

关键词：

D O I：

10.1136/annrheumdis-2014-eular.3979

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB1044

引用

页码：1145 / 1145

页数：1

共 50 条

[41] Improvement in patient-reported outcomes with rituximab in patients with rheumatoid arthritis
Pavelka, K
Nahir, AM
Edwards, JCW
Hassey, E
Saiedabadi, N
Shaw, T
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 289 - 290
[42] Inhibition of JNK in synovium by treatment with golimumab in rheumatoid arthritis
Katsuaki Kanbe
Junji Chiba
Atsushi Nakamura
Rheumatology International, 2014, 34 : 125 - 130
[43] Relationship of patient-reported outcomes with MRI measures in rheumatoid arthritis
Baker, Joshua F.
Conaghan, Philip G.
Emery, Paul
Baker, Daniel G.
Ostergaard, Mikkel
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (03) : 486 - 490
[44] PATIENT-REPORTED OUTCOMES AMONG TREATED RHEUMATOID ARTHRITIS PATIENTS
Feinberg, B. A.
Olson, T.
Burruss, R. A.
Garofalo, D. F.
VALUE IN HEALTH, 2016, 19 (03) : A237 - A237
[45] Chilblain lupus during treatment with golimumab for rheumatoid arthritis
Urata, Yoichiro
Honda, Tetsuya
Kaku, Yo
Kabashima, Kenji
JOURNAL OF DERMATOLOGY, 2019, 46 (09): : E314 - E315
[46] Patient Reported Outcomes in Rheumatoid Arthritis: Best Domain, Best Interface
Navarro-Millan, Iris
Cornelius-Schecter, Anna
Jagpal, Aprajita
Johnson, Bernadette
Fraenkel, Liana
Safford, Monika M.
Curtis, Jeffrey R.
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[47] Patient-reported outcomes and their-role in the assessment of rheumatoid arthritis
Lubeck, DP
PHARMACOECONOMICS, 2004, 22 (02) : 27 - 38
[48] Viral Hepatitis Influences Patient Reported Outcomes Measures in Rheumatoid Arthritis
Timilsina, Suraj
Sayles, Harlan
England, Bryant R.
O'Dell, James R.
Mikuls, Ted R.
Michaud, Kaleb
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[49] Evaluation of golimumab for the treatment of patients with active rheumatoid arthritis
Tanaka, Yoshiya
Senoo, Asako
Fujii, Hideji
Baker, Daniel
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (03) : 319 - 326
[50] Inhibition of JNK in synovium by treatment with golimumab in rheumatoid arthritis
Kanbe, Katsuaki
Chiba, Junji
Nakamura, Atsushi
RHEUMATOLOGY INTERNATIONAL, 2014, 34 (01) : 125 - 130

← 1 2 3 4 5 →